The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

2007

Stage

Acquired | Acquired

Total Raised

$16M

About Alize Pharma

Alize Pharma is a group of companies specialized in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic and rare diseases. Its business strategy is to advance programs based on medical innovation to the clinical stage and establish partnerships with pharmaceutical companies to secure both near and long-term revenue streams.

Alize Pharma Headquarter Location

15, chemin du Saquin Espace Europeen, Building G

Ecully, 69130,

France

+33 472 18 94 28

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Alize Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Alize Pharma is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Alize Pharma Patents

Alize Pharma has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/5/2015

3/20/2018

Excipients, Monoclonal antibodies, Cosmetics chemicals, Polymers

Grant

Application Date

8/5/2015

Grant Date

3/20/2018

Title

Related Topics

Excipients, Monoclonal antibodies, Cosmetics chemicals, Polymers

Status

Grant

Latest Alize Pharma News

Alize Pharma SAS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27082018 Prices from USD $250

Oct 16, 2018

02:39 EDT 16 Oct 2018 | BioPortfolio Reports Summary Alize Pharma SAS Alize Pharma, a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrelin for the treatment of metabolic and cardiovascular disorders including type 2 diabetes and PraderWilli syndrome. Alize Pharma owns pending and granted patents that protect the UAG analogs and therapeutic applications. The company partners with academic institutions in the Netherlands and Italy. Alize Pharma is headquartered in Lyon, France. Alize Pharma SAS Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • When was Alize Pharma founded?

    Alize Pharma was founded in 2007.

  • Where is Alize Pharma's headquarters?

    Alize Pharma's headquarters is located at 15, chemin du Saquin, Ecully.

  • What is Alize Pharma's latest funding round?

    Alize Pharma's latest funding round is Acquired.

  • How much did Alize Pharma raise?

    Alize Pharma raised a total of $16M.

  • Who are the investors of Alize Pharma?

    Investors of Alize Pharma include Millendo Therapeutics, Octalfa, CEMA, Sham Innovation Santé, InnoBio and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.